| Survivors | Non-survivors | P value |
---|---|---|---|
SPRINT cohort | n = 310 | n = 61 | Â |
Average BG, mmol/L | 6.1 (5.6–6.6) | 5.9 (5.5–6.5) | 0.55a |
Maximum BG, mmol/L | 9.9 (8.6–11.8) | 10.4 (8.5–12.1) | 0.62a |
BG range, mmol/L | 6.1 (4.7–8.1) | 6.5 (5.0–8.8) | 0.35a |
APACHE II score | 18.0 (14.0–22.0) | 25.0 (18.0–30.3) | <0.01a |
APACHE II risk of death | 23% (12%-41%) | 50% (26%-71%) | <0.01a |
Average percentage goal feed | 48% (0%-71%) | 54% (29%-68%) | 0.42a |
Average hourly insulin, U/hour | 2.7 (2.2–3.3) | 2.5 (2.1–3.2) | 0.65a |
Diabetic history | 56 (18.1%) | 6 (9.8%) | 0.12b |
Retrospective cohort | n = 336 | n = 77 | Â |
Average BG, mmol/L | 7.5 (6.6–8.4) | 7.3 (6.6–8.3) | 0.83a |
Maximum BG, mmol/L | 10.5 (9.4–12.6) | 11.3 (10.0–13.6) | 0.04a |
BG range, mmol/L | 5.8 (3.8–8.6) | 6.8 (4.7–9.5) | 0.05a |
APACHE II score | 18.0 (15.0–22.0) | 24.0 (18.8–29.0) | <0.01a |
APACHE II risk of death | 25% (13%-43%) | 51% (23%-67%) | <0.01a |
Average hourly insulin, U/hour | 0.8 (0.0–1.7) | 1.0 (0.5–1.5) | 0.33a |
Diabetic history | 58 (17.3%) | 13 (16.9%) | 0.94b |